1. “药物-材料-水”的分子间相互作用对制剂药剂学行为的影响:
我们在2015年提出了研究“药物-材料-水”的方法学,“χASD-water plot”(ASD和水的Flory-Huggins相互作用参数相对于ASD的载药量的变化, 图1),我们发现这一表征手段可以清晰揭示ASD中药物和高分子的相互作用强度、种类、以及在水作用下的变化,并且发现这些分子间相互作用和ASD的溶出密切相关。 当药物-高分子相互作用使得体系更为疏水,且这一相互作用不为水所破坏时,ASD表现出最佳溶出效果。这一工作首次确认了分子间相互作用和制剂溶出行为的关联。随后,我们在多个研究中验证了药物和材料之间的分子间相互作用,对制剂结构和表现的影响,这样的分子药剂学的研究思路也支持了多个新药的制剂研发。(Mol. Pharmaceutic, 2016, 13, 599–608; Mol. Pharmaceutic, 2016, 13, 2787-2795;Pharm Res, 2016, 33(10), 2445-2458;Cryst. Growth Des., 2016, 16, 5367-5376;Mol. Pharmaceutics, 2018, 15 (7), 2754–2763;Mol. Pharmaceutics, 2019, 16(1), pp 318–326; ACS Infect. Dis. 2020, 6, 5, 802–810;etc.)

清华大学-杨森研究员(Janssen-Tsinghua Investigator)
“Chemistry Leadership Award”, 百时美-施贵宝制药公司 (Bristol-Myers Squibb Company), 2008
代表性论文
1. Dou L, Liu H., Wang K, Liu J, Liu L, Ye J, Wang R, Deng H, Qian F.*; Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer, Journal of Controlled Release, 2022 Aug 4;349:876-889. doi: 10.1016/j.jconrel.2022.07.033.
2. Kong W, Liu Z, Sun M, Liu H, Kong C, Ma J, Wang R, Qian F.*; Synergistic Autophagy Blockade and VDR Signaling Activation Enhance Stellate Cell Reprogramming in Pancreatic Ductal Adenocarcinoma, Cancer Letters. 2022 Jul 28;539:215718. doi: 10.1016/j.canlet.2022.215718. Epub 2022 May 5.
3. Fang Yuan, Mengnan Sun, Zhengsheng Liu, Huiqin Liu, Weijian Kong, Rui Wang, Qian F*, Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer. Theranostics. 2022; 12(3): 1061-1073. doi: 10.7150/thno.65299
4. Liu H; Yu S; Qian F*, Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts, Advanced Drug Delivery Reviews, 2021 May;172:37-51. https://doi.org/10.1016/j.addr.2021.02.012
5. Zhou T,; Qian F.*; Adenosine Triphosphate-Induced Rapid Liquid–Liquid Phase Separation of a Model IgG1 mAb, Mol. Pharmaceutics. 2021 18 (1), 267-274, DOI: 10.1021/acs.molpharmaceut.0c00905
6. Mi W; Chen H; Zhu A, Zhang T, Qian F*, Melting point prediction of organic molecules by deciphering the chemical structure into a natural language, Chemical Communications, 2021, 57, 2633 – 2636
7. Yuan F; Sun M; Liu H; Qian, F.*, Albumin-conjugated drug is irresistible by single gene mutation of endocytic system: verification by genome-wide CRISPR-Cas9 loss-of function screens, Journal of Controlled Release, Vol 323, 10 July 2020, Pages 311-320
8. Hu C.; Liu Z.; Liu C.; Zhang Y.; Fan H.; Qian F.*; Improvement of Antialveolar Echinococcosis Efficacy of Albendazole by a Novel Nanocrystalline Formulation with Enhanced Oral Bioavailability, ACS Infect. Dis. 2020, 6, 5, 802–810
9. Kong C; Li Y; Liu Z; Ye J; Wang Z; Zhang L; Kong W.; Liu H.; Liu C.; Pang H.; Hu Z.; Gao J.; and Qian, F*, Targeting the Oncogene KRAS Mutant Pancreatic Cancer by Synergistic Blocking of Lysosomal Acidification and Rapid Drug Release, ACS Nano, DOI: 10.1021/acsnano.8b08246, March 26, 2019.
10. Liu H; Sun M; Liu Z; Kong C; Kong W; Ye J; Gong J; Huang D; Qian, F.*, KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs, Journal of Controlled Release, Vol 296, 28 February 2019, Pages 40-53.